Application of basic fibroblast growth factor may reverse diabetic wound healing impairment

Linda Phillips, K. M. Abdullah, P. D. Geldner, S. Dobbins, F. Ko, H. A. Linares, L. D. Broemeling, M. C. Robson

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This study examines the effect of application of basic fibroblast growth factor (bFGF) on the wound healing impairment seen in streptozotocin-induced diabetic (SD) rats compared with control nondiabetic (NL) animals. Under general anesthesia, a 6-cm dorsal incision was made through the skin and panniculus carnosus. Both the NL and SD wounds were injected with 0.1 ml of one of the following three solutions: saline, vehicle, and 10 μg of bFGF. The wounds were closed with interrupted sutures of 4-0 nylon. The animals were returned to their cages and sacrificed at 7, 10, 14, or 21 days later. Breaking strength of the wound was analyzed by using an Instron Tensiometer 4201 to assay for relative collagen maturation. Data among groups were compared using an analysis of variance. At 7 and 10 days, all NL wounds were stronger than all SD wounds. By 14 days there was no statistically significant difference in breaking strength between the bFGF-SD wounds and all subgroups of NL wounds. The bFGF-SD subgroup was statistically significantly stronger than the saline-SD (p < 0.02) and vehicle-SD (p < 0.01) wounds. At 21 days the bFGF-SD wounds were statistically significantly stronger than the vehicle-SD wounds to a confidence level of p < 0.001. These findings indicate that application of bFGF may reverse the impairment seen in diabetic wound healing.

Original languageEnglish (US)
Pages (from-to)331-334
Number of pages4
JournalAnnals of Plastic Surgery
Volume31
Issue number4
StatePublished - 1993

Fingerprint

Fibroblast Growth Factor 2
Wound Healing
Streptozocin
Wounds and Injuries
Nylons
Sodium Chloride
General Anesthesia
Sutures
Analysis of Variance
Collagen
Skin

ASJC Scopus subject areas

  • Surgery

Cite this

Phillips, L., Abdullah, K. M., Geldner, P. D., Dobbins, S., Ko, F., Linares, H. A., ... Robson, M. C. (1993). Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. Annals of Plastic Surgery, 31(4), 331-334.

Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. / Phillips, Linda; Abdullah, K. M.; Geldner, P. D.; Dobbins, S.; Ko, F.; Linares, H. A.; Broemeling, L. D.; Robson, M. C.

In: Annals of Plastic Surgery, Vol. 31, No. 4, 1993, p. 331-334.

Research output: Contribution to journalArticle

Phillips, L, Abdullah, KM, Geldner, PD, Dobbins, S, Ko, F, Linares, HA, Broemeling, LD & Robson, MC 1993, 'Application of basic fibroblast growth factor may reverse diabetic wound healing impairment', Annals of Plastic Surgery, vol. 31, no. 4, pp. 331-334.
Phillips L, Abdullah KM, Geldner PD, Dobbins S, Ko F, Linares HA et al. Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. Annals of Plastic Surgery. 1993;31(4):331-334.
Phillips, Linda ; Abdullah, K. M. ; Geldner, P. D. ; Dobbins, S. ; Ko, F. ; Linares, H. A. ; Broemeling, L. D. ; Robson, M. C. / Application of basic fibroblast growth factor may reverse diabetic wound healing impairment. In: Annals of Plastic Surgery. 1993 ; Vol. 31, No. 4. pp. 331-334.
@article{f01fa960c6934ccf984f38aa0f1f29fb,
title = "Application of basic fibroblast growth factor may reverse diabetic wound healing impairment",
abstract = "This study examines the effect of application of basic fibroblast growth factor (bFGF) on the wound healing impairment seen in streptozotocin-induced diabetic (SD) rats compared with control nondiabetic (NL) animals. Under general anesthesia, a 6-cm dorsal incision was made through the skin and panniculus carnosus. Both the NL and SD wounds were injected with 0.1 ml of one of the following three solutions: saline, vehicle, and 10 μg of bFGF. The wounds were closed with interrupted sutures of 4-0 nylon. The animals were returned to their cages and sacrificed at 7, 10, 14, or 21 days later. Breaking strength of the wound was analyzed by using an Instron Tensiometer 4201 to assay for relative collagen maturation. Data among groups were compared using an analysis of variance. At 7 and 10 days, all NL wounds were stronger than all SD wounds. By 14 days there was no statistically significant difference in breaking strength between the bFGF-SD wounds and all subgroups of NL wounds. The bFGF-SD subgroup was statistically significantly stronger than the saline-SD (p < 0.02) and vehicle-SD (p < 0.01) wounds. At 21 days the bFGF-SD wounds were statistically significantly stronger than the vehicle-SD wounds to a confidence level of p < 0.001. These findings indicate that application of bFGF may reverse the impairment seen in diabetic wound healing.",
author = "Linda Phillips and Abdullah, {K. M.} and Geldner, {P. D.} and S. Dobbins and F. Ko and Linares, {H. A.} and Broemeling, {L. D.} and Robson, {M. C.}",
year = "1993",
language = "English (US)",
volume = "31",
pages = "331--334",
journal = "Annals of Plastic Surgery",
issn = "0148-7043",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Application of basic fibroblast growth factor may reverse diabetic wound healing impairment

AU - Phillips, Linda

AU - Abdullah, K. M.

AU - Geldner, P. D.

AU - Dobbins, S.

AU - Ko, F.

AU - Linares, H. A.

AU - Broemeling, L. D.

AU - Robson, M. C.

PY - 1993

Y1 - 1993

N2 - This study examines the effect of application of basic fibroblast growth factor (bFGF) on the wound healing impairment seen in streptozotocin-induced diabetic (SD) rats compared with control nondiabetic (NL) animals. Under general anesthesia, a 6-cm dorsal incision was made through the skin and panniculus carnosus. Both the NL and SD wounds were injected with 0.1 ml of one of the following three solutions: saline, vehicle, and 10 μg of bFGF. The wounds were closed with interrupted sutures of 4-0 nylon. The animals were returned to their cages and sacrificed at 7, 10, 14, or 21 days later. Breaking strength of the wound was analyzed by using an Instron Tensiometer 4201 to assay for relative collagen maturation. Data among groups were compared using an analysis of variance. At 7 and 10 days, all NL wounds were stronger than all SD wounds. By 14 days there was no statistically significant difference in breaking strength between the bFGF-SD wounds and all subgroups of NL wounds. The bFGF-SD subgroup was statistically significantly stronger than the saline-SD (p < 0.02) and vehicle-SD (p < 0.01) wounds. At 21 days the bFGF-SD wounds were statistically significantly stronger than the vehicle-SD wounds to a confidence level of p < 0.001. These findings indicate that application of bFGF may reverse the impairment seen in diabetic wound healing.

AB - This study examines the effect of application of basic fibroblast growth factor (bFGF) on the wound healing impairment seen in streptozotocin-induced diabetic (SD) rats compared with control nondiabetic (NL) animals. Under general anesthesia, a 6-cm dorsal incision was made through the skin and panniculus carnosus. Both the NL and SD wounds were injected with 0.1 ml of one of the following three solutions: saline, vehicle, and 10 μg of bFGF. The wounds were closed with interrupted sutures of 4-0 nylon. The animals were returned to their cages and sacrificed at 7, 10, 14, or 21 days later. Breaking strength of the wound was analyzed by using an Instron Tensiometer 4201 to assay for relative collagen maturation. Data among groups were compared using an analysis of variance. At 7 and 10 days, all NL wounds were stronger than all SD wounds. By 14 days there was no statistically significant difference in breaking strength between the bFGF-SD wounds and all subgroups of NL wounds. The bFGF-SD subgroup was statistically significantly stronger than the saline-SD (p < 0.02) and vehicle-SD (p < 0.01) wounds. At 21 days the bFGF-SD wounds were statistically significantly stronger than the vehicle-SD wounds to a confidence level of p < 0.001. These findings indicate that application of bFGF may reverse the impairment seen in diabetic wound healing.

UR - http://www.scopus.com/inward/record.url?scp=0027376209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027376209&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 331

EP - 334

JO - Annals of Plastic Surgery

JF - Annals of Plastic Surgery

SN - 0148-7043

IS - 4

ER -